Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients

To assess the cost-effectiveness of utilizing IDegLira in comparison to other treatment regimens ( liraglutide and degludec) in managing type 2 diabetes, taking into account the Chinese healthcare system ’s per...

Source: Diabetology and Metabolic Syndrome - August 19, 2023 Category: Endocrinology Authors: Ran Wei, Weihao Wang, Xiusheng Huang, Jingtao Qiao, Jinghe Huang, Chang Xing, Qi Pan and Lixin Guo Tags: Research Source Type: research